Fidelity Investments’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Fidelity Investments’s Portfolio REVS Stock Details REVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.3K	Sell	456 -3,467	-88%	-$107K	﹤0.01%	4777
2026 Q1	$112K	Buy	3,923 +3,817	+3,601%	+$111K	﹤0.01%	3747
2025 Q4	$3.01K	Hold	106	–	–	﹤0.01%	4974
2025 Q3	$2.97K	Hold	106	–	–	﹤0.01%	4885
2025 Q2	$2.79K	Hold	106	–	–	﹤0.01%	4811
2025 Q1	$2.68K	Sell	106 -107	-50%	-$2.72K	﹤0.01%	4835
2024 Q4	$5.26K	Hold	213	–	–	﹤0.01%	4663
2024 Q3	$5.4K	Buy	+213	New	+$5.18K	﹤0.01%	4610
2022 Q1	–	Sell	-1	Closed	–	–	5395
2021 Q4	$0	Buy	+1	New	+$21	﹤0.01%	4836

Other funds holding REVS

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FIB

First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ruggaard & Associates Hudson, Ohio $279M AUM 18.61% 1-Year Est. Return

Fidelity Investments's REVS Position: Q2 2026 in Review

Fidelity Investments reduced its Columbia Research Enhanced Value ETF (REVS) stake by 88% in Q2 2026, selling an estimated $107K and leaving 456 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4777.

Fidelity Investments first reported a position in REVS in Q4 2021 and has held it in 9 quarters since. The position peaked at $112K in Q1 2026. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

Fidelity Investments held 456 shares of Columbia Research Enhanced Value ETF worth $14.3K as of Q2 2026.
Fidelity Investments sold 3,467 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $107K.
Columbia Research Enhanced Value ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4777 holding.
Fidelity Investments first reported a position in Columbia Research Enhanced Value ETF in Q4 2021 and has held it in 9 quarters since.
Fidelity Investments's Columbia Research Enhanced Value ETF position peaked at $112K in Q1 2026.
38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.